Fact CheckerSign in

NCT07470515Not yet recruiting

Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot Study

Fiber-Optic Navigation During Transjugular Intrahepatic Portosystemic Shunt Creation: A Prospective Pilot Study Evaluating Procedural Parameters

Source: ClinicalTrials.gov · Last updated 13 Mar 2026

Brief summary (registry, in English)

Transjugular intrahepatic portosystemic shunt (TIPS) creation is an established minimally invasive treatment for complications of portal hypertension such as refractory ascites and variceal bleeding. A technically challenging step of the procedure is the puncture of the portal vein from the hepatic vein, which is usually performed under fluoroscopic guidance and may require multiple puncture attempts. This prospective pilot study evaluates the use of fiber-optic navigation technology during TIPS creation. The system allows real-time three-dimensional visualization of guidewires and catheters and may improve spatial orientation during the procedure. Approximately 30 patients with a clinical indication for TIPS placement will be included. The study will assess procedural parameters such as the number of puncture attempts, fluoroscopy time, radiation exposure, procedure duration, technical success, and complications. The results may help to improve procedural efficiency and radiation safety during TIPS interventions.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
10 Mar 2026
Start date
Jan 2027
Primary completion date
Jun 2028
Lead sponsor
Medical University Innsbruck
NCT number
NCT07470515

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From Jan 2027 to the primary completion date, Jun 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Absolute contraindications to TIPS according to current clinical standards (e.g., severe right heart failure, uncontrolled systemic infection)

Other

  • Inability or unwillingness to provide informed consent
  • Pregnancy or breastfeeding
  • Participation in another clinical study that may interfere with the results of this study

Who the study is looking for

  • Age ≥ 18 years
  • Clinical indication for transjugular intrahepatic portosystemic shunt (TIPS) creation according to standard clinical practice (e.g., refractory ascites or variceal bleeding)
  • Ability to provide written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University of Innsbruck
Coordinator of this site? Confirm its status
InnsbruckAustriaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.